April US FDA Approval Decisions To Cover Cardiomyopathy, CNS And China-Developed Cancer Drugs
Five novel agents have user fee goal dates in the coming month, the Pink Sheet’s US FDA Performance Tracker shows.
Five novel agents have user fee goal dates in the coming month, the Pink Sheet’s US FDA Performance Tracker shows.